Table 2.
Round three survey codes, definitions, and kappa values.
| Code | Definition | Kappa |
| Behaviors/lifestyle | Includes patient health behaviors or lifestyle choices (eg, smoking, healthy eating) | >.99 |
| Comorbidity | Mention of having multiple health problems at once (COPDa and asthma) | >.99 |
| Coordination | Individuals working together or planning together for a common purpose; includes working as a team | .90 |
| Coping | Patient strategies or discussion of ways to deal with health issues caused by or related to COPD | .91 |
| Cost | Refers to money needed or spent on the care, management, or treatment of COPD | >.99 |
| Diagnosis | Diagnosis of COPD or the health issues (eg, diagnosis of depression) stemming from COPD symptoms | .91 |
| Doctor visits | Visits to health care providers that are involved in the treatment of COPD, NOT including emergency room visits | >.99 |
| Patient education | References to the need to learn more or increase understanding about COPD, the treatments of COPD, or anything else related to COPD | .93 |
| Effectiveness | References to the effectiveness of COPD treatments to manage or prevent health issues; include cost effectiveness; comparison benefits versus negative effects | .95 |
| Emergency room visits | Mention of the occurrence or prevention of emergency room visits due to COPD symptoms or complications | >.99 |
| Expectation | References to the patient’s expectation of COPD and its treatment | .80 |
| Follow-up | Mention of the patient or provider following up on a treatment or issue related to COPD | .80 |
| Health effects | Mentions of any health outcome related to COPD or symptoms of COPD (eg, breathing issues) | .94 |
| Home | Reference to the in-home care or treatment of COPD | >.99 |
| Hospital stay | Mention of having to stay at a hospital for a day or more for a treatment related to COPD; hospital visit outside of a regular doctor visit; not including emergency room visits | >.99 |
| Informed | Mention of all individuals involved or affected by COPD having the knowledge to make appropriate or proper decisions about treatment or care | .95 |
| Limitations | Reference to the downfalls or possible cons of a treatment or care strategy for COPD | >.99 |
| Management | General references to managing COPD | .96 |
| Medicine | Mention of any type of medicine taken to treat COPD or health issues related to COPD | >.99 |
| Mental health | Mention of mental health concerns, such as depression, stemming from COPD diagnosis, symptoms, or treatment | >.99 |
| Monitor | Monitoring the progress or effects of COPD symptoms and treatment | >.99 |
| Necessary/helpful | Reference to someone or something being necessary, sufficient, or helpful in the COPD treatment or management | .99 |
| Death | Discussion or reference to passing away | >.99 |
| Patient-provider communication | Reference to the communication or lack thereof between a patient and the health care providers involved in their treatment | >.99 |
| Personal experience | A patient or provider references a specific event that occurred related to diagnosis or treatment of COPD | >.99 |
| Personalization | Reference to the unique factors of patients and the need for individualized treatment, care, or consideration | .96 |
| Prevention | Reference to the strategies and need for preventing COPD or the complications of COPD | >.99 |
| Health-related quality of life | Reference to quality of life, such as the importance or the negative/positive effects that COPD has on quality of life | .86 |
| Standardize | Reference to the standardization of treatment options and management of COPD for patients | .75 |
| Statistics | References to numerical data related to COPD, such as number of deaths caused by COPD or the number of people living with COPD | .80 |
aChronic obstructive pulmonary disease